PDS Biotechnology (PDSB) Other Operating Expenses (2014 - 2026)
PDS Biotechnology's (PDSB) quarterly Other Operating Expenses came in at -$359149.0 in Q4 2025, down 4.35% YoY from -$375473.3 in Q4 2024, and up 0.66% on a QoQ basis from -$361546.0 in Q3 2025.
PDS Biotechnology (PDSB) Other Operating Expenses (2014 - 2026) Analysis & Trends
PDS Biotechnology (PDSB) has 8 years of Other Operating Expenses data on file, last reported at -$359149.0 in Q4 2025.
- Quarterly Other Operating Expenses fell 4.35% year-over-year to -$359149.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$1.5 million (down 0.98% YoY) and the FY2025 annual result came in at -$1.5 million, down 0.98% from the prior year.
- Other Operating Expenses grew to -$359149.0 in Q4 2025, from -$361546.0 in the prior quarter.
- In the past five years, Other Operating Expenses ranged from a high of -$344185.0 in Q4 2024 to a low of -$387897.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | PDS Biotechnology | 12.02 Mn | 12.02 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -309,370.00 |
| Dec 31, 2025 | -359,149.00 |
| Sep 30, 2025 | -361,546.00 |
| Jun 30, 2025 | -387,897.00 |
| Mar 31, 2025 | -344,354.00 |
| Dec 31, 2024 | -344,185.00 |
| Sep 30, 2024 | -351,081.00 |
| Jun 30, 2024 | -378,905.00 |
| Mar 31, 2024 | -364,662.00 |
| Dec 31, 2019 | -34,828.00 |
| Sep 30, 2019 | -944,445.00 |
| Jun 30, 2018 | -6.65 Mn |
| Dec 31, 2017 | 860.00 |
| Dec 31, 2016 | 201.00 |
| Sep 30, 2016 | 208.00 |
| Jun 30, 2016 | -195.00 |
| Mar 31, 2016 | -360.00 |
| Dec 31, 2015 | -380.00 |
| Sep 30, 2015 | 140.00 |
| Jun 30, 2015 | 691.00 |